Yusuke Tanigawara (Y Tanigawara)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Peritoneal Dialysis

Bone Mineral Density

Squamous Cell Carcinoma

Top Venues

CPT: pharmacometrics & systems pharmacology

Metabolomics : Official journal of the Metabolomic Society

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Otani, Yunqi Zhao, Guanyu Wang, Richard Labotka, Mark Rogge, Neeraj Gupta, Majid Vakilynejad, Dean Bottino, Yusuke Tanigawara
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone. CPT: pharmacometrics & systems pharmacology (2024)
Takahiro Tsushima, Hidefumi Kasai, Yusuke Tanigawara
Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer. Cancer chemotherapy and pharmacology 86 (4) (2020)
Y Mori, H Kasai, A Ose, M Serada, M Ishiguro, M Shiraki, Yusuke Tanigawara
Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 29 (5) (2018)
Takahisa Kawamura, Hidefumi Kasai, Valentina Fermanelli, Toshiaki Takahashi, Yukinori Sakata, Toshiyuki Matsuoka, Mika Ishii, Yusuke Tanigawara
Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance data. Cancer science 109 (9) (2018)
Kayoko Yoshida, Chiyo K Imamura, Kanako Hara, Mayumi Mochizuki, Yusuke Tanigawara
Effect of everolimus on the glucose metabolic pathway in mouse skeletal muscle cells (C2C12). Metabolomics : Official journal of the Metabolomic Society 13 (8) (2017)